Save
Email
Print
Share
RSSBrowse News Stories
11 to 20 of 112 stories
view headlines only
-
Immune System Harnessed to Improve Stem Cell Transplant Outcomes
October 1, 2012 — A novel therapy in the early stages of development shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer ... > full story -
Molecule Shows Effectiveness Against Drug-Resistant Myeloma
September 10, 2012 — A molecule that targets the cell's machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers report. P5091 triggered ... > full story -
Possible New Therapy for the Treatment of a Common Blood Cancer
September 5, 2012 — Research from in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms ... > full story -
Scientists Devise New Strategy to Destroy Multiple Myeloma
August 14, 2012 — Researchers are reporting promising results from laboratory and animal experiments involving a new combination therapy for multiple myeloma, the second most common form of blood ... > full story -
Shedding Light on Carfilzomib, a Promising New Multiple Myeloma Therapy
July 25, 2012 — Three separate multi-center studies have been conducted with the new proteasome inhibitor carfilzomib. Carfilzomib is a novel, highly selective proteasome inhibitor, a type of medication that blocks ... > full story -
Surprising Culprit Behind Chemo Resistance in Rare Cancer
July 2, 2012 — Researchers have shown how an aggressive form of multiple myeloma resists chemotherapy. Multiple myeloma is a rare cancer of plasma cells in the bone marrow. Though the finding has no immediate ... > full story -
Stopping and Starting Cancer Cell Cycle Weakens and Defeats Multiple Myeloma
June 21, 2012 — Researchers have devised an innovative boxer-like strategy, based on the serial use of two anti-cancer drugs, to deliver a one-two punch to first weaken the defenses of multiple myeloma and then ... > full story -
Nanoparticles Hold Promise to Improve Blood Cancer Treatment
June 15, 2012 — Researchers have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone ... > full story -
Type 2 Diabetes Linked to Increased Blood Cancer Risk
June 5, 2012 — A new meta-analysis reveals patients with type 2 diabetes have a 20 percent increased risk of developing blood ... > full story -
Immune System Glitch Tied to Fourfold Higher Likelihood of Death Identified
June 4, 2012 — High levels of an antibody molecule has been found to be linked to increased rates of death from all ... > full story
Search ScienceDaily
Number of stories in archives: 140,690
more 
